Natália dos Santos Gonçalves

Natália dos Santos Gonçalves

Auto-generated profile, based on publicly available information

Natália dos Santos Gonçalves

Laboratory of Genetics and Molecular Biology, University of Franca

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2025 in Natural Product Research
Verified
Journal Article
Closed access
JPJulia Mirian Paulino
Julia Mirian Paulino
NGNatália dos Santos Gonçalves
Natália dos Santos Gonçalves
AHAndrada Eduardo Heber
Andrada Eduardo Heber
ARArthur Barcelos Ribeiro
Arthur Barcelos Ribeiro
Carlos H.I. RamosCarlos H.I. Ramos
Carlos H.I. Ramos
RSRaquel Alves Dos Santos
Raquel Alves Dos Santos
The present study investigated the cellular inhibitory effects of cis-trimethoxystilbene (cis-TMS) on the chemoresistant MDA-MB-231 breast cancer cell line and the role of p53 in mediating the cellular responses to this compound. Treatment with cis-TMS significantly inhibited the growth of MDA-MB-231 cells, reducing the cell viability by approximately 75% at 2.5 µM and increasing apoptosis rates to nearly 20%. Silencing p53 in MCF-10A and MCF-7 cell lines revealed that cis-TMS-induced apoptosis and cell cycle arrest were p53-dependent. The interaction studies suggest that cis-TMS does not alter the conformation of p53 at low concentrations but may influence its activity at higher doses. The results suggest that cis-TMS selectively targets cancer cells with functional p53, offering a potential targeted therapy approach. However, the reliance on p53 and the risk of genomic instability pose limitations, requiring further research to optimise the therapeutic strategies involving cis-TMS.